Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03567642
Title A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Etoposide + Osimertinib

Cisplatin + Etoposide + Osimertinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth Recruiting Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Recruiting Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Recruiting Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Recruiting Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Recruiting Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field